Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.7 USD | -1.09% | +0.04% | +0.91% |
Apr. 30 | UBS Adjusts Price Target on Methanex to $60 From $62, Maintains Buy Rating | MT |
Apr. 26 | Methanex Price Target Raised to US$50 at RBC | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company sustains low margins.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.91% | 3.25B | - | ||
+3.41% | 103B | A- | ||
+1.20% | 67.05B | A- | ||
+44.29% | 40.4B | B | ||
+15.99% | 38.64B | B | ||
+4.25% | 32.41B | A- | ||
+5.39% | 19.17B | B- | ||
+12.32% | 16.76B | C+ | ||
+17.69% | 15.07B | B- | ||
+8.31% | 14.82B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MX Stock
- MEOH Stock
- Ratings Methanex Corporation